Home / Stocks / INFU

InfuSystem Holdings (INFU, Health Care Services) Stock Valuation & Fair Value Trading above fair value

InfuSystem Holdings (INFU, Health Care Services) trades at a blended P/E of 30.8, about 58% below its historical normal valuation, with a forward growth estimate of 18.1% and a PEG of 1.70. Analysts' one-year estimates have been hit 33% of the time. Priced at its historical normal P/E of 74.0 on the same blended earnings, the 2026-09-18 close of $12.85 corresponds to about $30.90 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-09-21
Blended P/E
30.8
Normal P/E
74.0
PEG
1.70
Fwd growth
18.1%
Div yield
0.0%
RSI (14)
70.6
Overbought

Valuation flags

Verdict history

tickerseer's rating moved from quality business with a solid forward outlook (2026-07-31) to trading above fair value (2026-09-21).

Blended P/E and rating by weekBlended P/E moved from 24.2 to 30.8 between 2026-07-31 and 2026-09-21, against a normal P/E of 74.0, with 1 rating change over 18 recorded weeks.2026-07-31: P/E 24.2, Quality business with a solid forward outlook (recalculated)2026-08-03: P/E 24.1, Quality business with a solid forward outlook2026-08-07: P/E 24.1, Quality business with a solid forward outlook (recalculated)2026-08-10: P/E 31.7, Quality business with a solid forward outlook2026-08-14: P/E 31.7, Quality business with a solid forward outlook (recalculated)2026-08-17: P/E 30.9, Quality business with a solid forward outlook2026-08-21: P/E 30.9, Quality business with a solid forward outlook (recalculated)2026-08-24: P/E 30.6, Quality business with a solid forward outlook2026-08-27: P/E 30.6, Quality business with a solid forward outlook (recalculated)2026-08-28: P/E 30.6, Quality business with a solid forward outlook (recalculated)2026-08-30: P/E 30.6, Quality business with a solid forward outlook (recalculated)2026-08-31: P/E 29.5, Quality business with a solid forward outlook2026-09-05: P/E 29.5, Quality business with a solid forward outlook (recalculated)2026-09-07: P/E 29.7, Quality business with a solid forward outlook2026-09-12: P/E 29.7, Quality business with a solid forward outlook (recalculated)2026-09-14: P/E 29.3, Trading above fair value2026-09-19: P/E 29.3, Trading above fair value (recalculated)2026-09-21: P/E 30.8, Trading above fair value40.060.0Jul 31Aug 13Aug 26Sep 8Sep 21Normal P/E 74.0
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-31P/E 24.2-67%Quality business with a solid forward outlook
2026-08-03P/E 24.1-67%Quality business with a solid forward outlook
2026-08-10P/E 31.7-57%Quality business with a solid forward outlook
2026-09-14P/E 29.3-60%Trading above fair value
2026-09-21P/E 30.8-58%Trading above fair value ← now

Frequently asked questions

Is InfuSystem Holdings stock overvalued?

At a blended P/E of 30.8 versus its historical normal P/E of 74.0, InfuSystem Holdings trades about 58% below its typical valuation, with a PEG of 1.70 on 18.1% forward growth. tickerseer currently rates it trading above fair value.

What is InfuSystem Holdings's fair value and PEG?

InfuSystem Holdings trades at a blended P/E of 30.8 against a historical normal P/E of 74.0, a PEG of 1.70, and a forward growth estimate of 18.1%. Priced at its historical normal P/E of 74.0 on the same blended earnings, the 2026-09-18 close of $12.85 corresponds to about $30.90 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of InfuSystem Holdings changed?

tickerseer's rating moved from quality business with a solid forward outlook (2026-07-31) to trading above fair value (2026-09-21).

Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track INFU free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.